Capital Advisors Ltd. LLC Increases Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Capital Advisors Ltd. LLC grew its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 31.9% during the third quarter, HoldingsChannel reports. The institutional investor owned 124 shares of the medical equipment provider’s stock after buying an additional 30 shares during the period. Capital Advisors Ltd. LLC’s holdings in Intuitive Surgical were worth $61,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently modified their holdings of the business. LVW Advisors LLC grew its stake in Intuitive Surgical by 13.3% in the 1st quarter. LVW Advisors LLC now owns 1,201 shares of the medical equipment provider’s stock worth $479,000 after acquiring an additional 141 shares in the last quarter. Aviance Capital Partners LLC purchased a new stake in shares of Intuitive Surgical in the 1st quarter worth $612,000. Diversified Trust Co grew its position in shares of Intuitive Surgical by 7.9% during the 1st quarter. Diversified Trust Co now owns 6,574 shares of the medical equipment provider’s stock worth $2,624,000 after buying an additional 479 shares in the last quarter. Miracle Mile Advisors LLC raised its holdings in shares of Intuitive Surgical by 2.8% in the 1st quarter. Miracle Mile Advisors LLC now owns 1,478 shares of the medical equipment provider’s stock valued at $590,000 after purchasing an additional 40 shares in the last quarter. Finally, Claro Advisors LLC lifted its position in shares of Intuitive Surgical by 25.0% in the 1st quarter. Claro Advisors LLC now owns 819 shares of the medical equipment provider’s stock worth $327,000 after purchasing an additional 164 shares during the period. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other Intuitive Surgical news, Director Amal M. Johnson sold 2,943 shares of the company’s stock in a transaction on Thursday, August 1st. The shares were sold at an average price of $443.30, for a total value of $1,304,631.90. Following the sale, the director now directly owns 12,275 shares of the company’s stock, valued at approximately $5,441,507.50. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other Intuitive Surgical news, Director Amy L. Ladd sold 450 shares of the business’s stock in a transaction that occurred on Friday, September 13th. The stock was sold at an average price of $490.28, for a total value of $220,626.00. Following the completion of the transaction, the director now directly owns 821 shares of the company’s stock, valued at approximately $402,519.88. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Amal M. Johnson sold 2,943 shares of the company’s stock in a transaction that occurred on Thursday, August 1st. The stock was sold at an average price of $443.30, for a total value of $1,304,631.90. Following the completion of the sale, the director now owns 12,275 shares in the company, valued at approximately $5,441,507.50. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 51,816 shares of company stock worth $25,230,649. 0.90% of the stock is owned by company insiders.

Analyst Ratings Changes

Several equities analysts recently issued reports on ISRG shares. Piper Sandler reissued an “overweight” rating and set a $538.00 price objective (up from $495.00) on shares of Intuitive Surgical in a report on Friday, October 18th. JPMorgan Chase & Co. lifted their price target on Intuitive Surgical from $495.00 to $575.00 and gave the company an “overweight” rating in a report on Friday, October 11th. Redburn Atlantic upgraded Intuitive Surgical from a “neutral” rating to a “buy” rating and upped their price objective for the stock from $380.00 to $510.00 in a research note on Friday, August 2nd. The Goldman Sachs Group set a $604.00 price objective on Intuitive Surgical in a research report on Friday, October 18th. Finally, Mizuho increased their price target on shares of Intuitive Surgical from $440.00 to $500.00 in a research report on Thursday, October 17th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have issued a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $513.74.

Intuitive Surgical Stock Performance

Shares of ISRG stock opened at $511.27 on Monday. Intuitive Surgical, Inc. has a fifty-two week low of $254.85 and a fifty-two week high of $523.34. The firm has a market capitalization of $182.10 billion, a PE ratio of 82.20, a P/E/G ratio of 5.11 and a beta of 1.39. The stock’s 50-day simple moving average is $487.98 and its 200-day simple moving average is $443.05.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.